Big Pharma may have to face consequences of DES-breast cancer link in court

Thursday, January 12, 2012 by: Tara Green
Tags: DES, breast cancer, lawsuit

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
Biologist explains how marijuana causes tumor cells to commit suicide
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
NJ cops bust teenagers shoveling snow without a permit
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
(NaturalNews) The first-ever lawsuit hinging on the link between DES and breast cancer may soon come to court in Boston. Fifty-three DES daughters are attempting to sue 14 drug manufacturers for the health consequences of one of the pharmaceutical industry's more notorious products.

Big Pharma trying to avoid lawsuit

The synthetic estrogen DES or diethylstilbestrol (day-eth-uhl-stil-bes'-trawl) was prescribed to millions of pregnant women from 1938 until 1971 to prevent miscarriages. In 1971, the FDA told doctors to stop prescribing the drug for pregnant women after a study indicated the pharmaceutical hormone broke through the uterine barrier and had an impact on children later in life. DES taken during pregnancy is linked to DES daughters developing a rare vaginal cancer in their teens and 20s. Since the early 70s, thousands of lawsuits have been filed regarding links between DES and cancers, as well as infertility problems. Many of those cases were settled out of court.

The Boston case is the first one to focus on the link between DES and breast cancer in DES daughters over the age of 40. Lawyers for the women suing the pharmaceutical firms are citing a study published in the New England Journal of Medicine in October 2011 which says DES daughters over age 40 have double the normal the risk of developing breast cancer. The National Cancer Institute study put the chance for DES daughters at 1 in 25, compared to a 1 in 50 chance for the average woman.

Attorneys for the plaintiffs say that DES drug manufacturing companies such as Bristol-Myers Squibb and Eli Lilly knew of the DES risks but suppressed the information. "This drug, DES, was the biggest human experiment of quackery in the history of medicine," said Aaron Levine, the attorney who filed the Boston lawsuit.

The drug companies deny the DES-breast cancer link. Eli Lilly's most recent annual report stated "We believe these claims are without merit and are prepared to defend against them vigorously." Drug companies state that the recent study is not conclusive and that there is no general acceptance in the medical community that fetal exposure to DES causes breast cancer. Lawyers for the pharmaceutical firms are moving for the case to be dismissed, arguing that the plaintiffs side is not scientifically reliable.

The judge in the case has heard testimony from experts on both sides. Final arguments on whether or not the case will go to trial are scheduled for January 19, 2012. Depending on whether the case goes to court and how it is decided, it may lead to similar cases by other DES daughters diagnosed with breast cancer.

Lingering health consequences of DES

Several of the DES daughters involved in the case say that, due to their knowledge of their mothers taking the drug while carrying them, they were extremely vigilant in regard to their health. They exercised, ate low fat diets, received the frequent screenings recommended by their doctors and avoided exposure to known risk factors such as birth control pills.

Yet they not only developed breast cancer, but in many cases, particularly fast-spreading versions of the cancer. One of the plaintiffs in the case, Arline MacCormack of Newton, Massachusetts, stated "The characteristics of my cancer were for women over 60 typically. It wasn't the type of cancer a 40-year-old or a 44-year-old woman gets." Another of the plaintiffs, Jackie White of Centerburg, Ohio, said she became suspicious that DES caused her cancer after seeing the high estrogen levels in her pathology reports.

A Centers for Disease Control and Prevention fact sheet on DES and breast cancer makes note of the research linking the two. The federal agency's information sheet states "Studies have shown a 30 percent increased risk for breast cancer among women prescribed DES while pregnant than among women who weren't prescribed DES." The CDC also notes the recent National Cancer Institute research on DES daughters and while acknowledging that "findings of the study are not definitive," the agency recommends early detection of breast cancer for women exposed to DES.


Follow real-time breaking news headlines on
DES at
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of, the internet's No. 1 natural health news site. (Source:

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.